China Meheco Group News

China Pharmaceuticals: Announcement on Subsidiaries Obtaining Drug Registration Approvals

Dec 4 11:00 ET

China Pharmaceutical: Notice on Subsidiaries Obtaining Approval Notice for Drug Supplementary Applications

Dec 2 11:00 ET

China Pharmaceutical Investor Relations Activity Record Form

Nov 27 22:30 ET

Announcement of Resolutions of the 21st Meeting of the 9th Board of Directors

Nov 27 11:00 ET

General Technology Liaoning Pharmaceutical Co., Ltd. Shareholders\' Total Equity Value Asset Assessment Report

Nov 27 11:00 ET

General Technology Liaoning Pharmaceutical Co., Ltd. 2023 Audit Report

Nov 27 11:00 ET

Related Party Fund Transaction Management System (2024 Revision)

Nov 27 11:00 ET

Announcement on renewal of office buildings and related transactions

Nov 27 11:00 ET

Notice on the change of accounting firm

Nov 27 11:00 ET

Minutes of China Pharmaceutical\'s 2024 Third Quarter Results Briefing

Nov 3 19:35 ET

China Pharmaceutical: Announcement on Subsidiary Drugs Passing Conformity Assessment of Generic Drugs

Oct 28 12:00 ET

China Pharmaceutical: Notice on Subsidiaries Obtaining Approval Notice for Drug Supplementary Applications

Oct 28 12:00 ET

Investor Relations Management Work System (2024 Revision)

Oct 25 12:00 ET

Fund Raising Management System (2024 Revision)

Oct 25 12:00 ET

External guarantee management system (2024 revision)

Oct 25 12:00 ET

Announcement of Resolutions of the 20th Meeting of the 9th Board of Directors

Oct 25 12:00 ET

Announcement on holding the results briefing for the third quarter of 2024

Oct 25 12:00 ET

Announcement on holding the 2024 semi-annual results briefing

Aug 28 12:00 ET

Announcement of the resolution of the 10th meeting of the 9th Supervisory Board.

Aug 20 12:00 ET

Risk Continual Assessment Report of General Technology Group Finance Co., Ltd.

Aug 20 12:00 ET